A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment.
Song JS, Chang CC, Wu CH, Dinh TK, Jan JJ, Huang KW, Chou MC, Shiue TY, Yeh KC, Ke YY, Yeh TK, Ta YN, Lee CJ, Huang JK, Sung YC, Shia KS, Chen Y.
Song JS, et al. Among authors: huang jk, huang kw.
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):e2015433118. doi: 10.1073/pnas.2015433118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33753481
Free PMC article.